| Name | HCV-IN-29 | CAS# | 1009119-83-8 | |
|---|---|---|---|---|
| Price | ¥Inquiry/100mg ¥Inquiry/250mg ¥Inquiry/1g | Purity | 98.0% | |
| Stocking Period |
1 Day | Stock | 3 | |
| Product Webpage: | https://www.dcchemicals.com/product_show-hcv-in-29.html | |||
| Detail
Product Information
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e. |
Get all suppliers by the below link:
| 2024-07-15 |
HCV-IN-29
Price: Inquiry |
| 2019-03-05 |
HCV-IN-29
Price: ¥4766.0 |
| 2021-07-26 |
1H-Imidazole,5,5,-[1,1,-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-,hydrochloride (1:4)
Price: $Inquiry |
| 2024-01-09 |
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
Price: $Inquiry |
| 2017-07-26 |
1H-IMidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)
Price: ¥Inquiry |
| 2022-08-18 |
HCV-IN-29
Price: ¥Inquiry |
| 2018-04-19 |
HCV-IN-29
Price: ¥Inquiry |
| 2024-04-24 |
BMS-790052
Price: ¥Inquiry |
| 2021-05-10 |
HCV-IN-29
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


